$2.5 Billion is the total value of HealthCor Management, L.P.'s 72 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 88.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $122,920,000 | +1.1% | 764,330 | +0.6% | 4.91% | +14.2% |
| BIIB | Buy | BIOGEN INC | $117,489,000 | +421.6% | 339,300 | +321.4% | 4.70% | +489.2% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $115,650,000 | -27.2% | 1,235,048 | -28.4% | 4.62% | -17.7% |
| WOOF | Buy | PETCO HEALTH & WELLNESS CO I | $110,805,000 | +61.9% | 4,944,450 | +60.1% | 4.43% | +82.9% |
| REGN | New | REGENERON PHARMACEUTICALS | $106,335,000 | – | 190,380 | +100.0% | 4.25% | – |
| HUM | Sell | HUMANA INC | $105,823,000 | +0.4% | 239,030 | -4.9% | 4.23% | +13.4% |
| CVS | New | CVS HEALTH CORP | $105,746,000 | – | 1,267,330 | +100.0% | 4.23% | – |
| DHR | Sell | DANAHER CORPORATION | $103,297,000 | -14.3% | 384,920 | -28.1% | 4.13% | -3.2% |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $98,517,000 | – | 1,474,370 | +100.0% | 3.94% | – |
| TMO | New | THERMO FISHER SCIENTIFIC INC | $92,303,000 | – | 182,970 | +100.0% | 3.69% | – |
| NTRA | New | NATERA INC | $89,650,000 | – | 789,658 | +100.0% | 3.58% | – |
| EHC | Buy | ENCOMPASS HEALTH CORP | $82,346,000 | +0.0% | 1,055,316 | +5.0% | 3.29% | +13.0% |
| MDT | Sell | MEDTRONIC PLC | $74,567,000 | -20.7% | 600,720 | -24.5% | 2.98% | -10.4% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $72,575,000 | +87.5% | 118,780 | +66.2% | 2.90% | +111.9% |
| SYK | New | STRYKER CORPORATION | $70,956,000 | – | 273,190 | +100.0% | 2.84% | – |
| NVRO | New | NEVRO CORP | $62,392,000 | – | 376,330 | +100.0% | 2.49% | – |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $52,396,000 | -39.1% | 1,255,597 | -48.0% | 2.09% | -31.2% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $51,764,000 | +14.0% | 1,210,570 | +3.0% | 2.07% | +28.7% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $51,352,000 | +3.3% | 3,248,100 | -33.5% | 2.05% | +16.8% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $50,377,000 | -14.0% | 1,165,860 | -18.8% | 2.01% | -2.8% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $47,674,000 | – | 325,577 | +100.0% | 1.91% | – |
| ZTS | Sell | ZOETIS INCcl a | $42,708,000 | -35.7% | 229,170 | -45.7% | 1.71% | -27.4% |
| VEEV | Buy | VEEVA SYS INC | $42,314,000 | +88.6% | 136,080 | +58.4% | 1.69% | +113.0% |
| AMGN | New | AMGEN INC | $38,581,000 | – | 158,280 | +100.0% | 1.54% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $37,953,000 | – | 389,980 | +100.0% | 1.52% | – |
| VRTX | VERTEX PHARMACEUTICALS INCcall | $37,705,000 | -6.2% | 187,000 | 0.0% | 1.51% | +6.0% | |
| WELL | Sell | WELLTOWER INC | $36,114,000 | -45.6% | 434,590 | -53.1% | 1.44% | -38.5% |
| HCA | Sell | HCA HEALTHCARE INC | $35,086,000 | -55.1% | 169,710 | -59.1% | 1.40% | -49.3% |
| MCK | Sell | MCKESSON CORP | $30,744,000 | -66.7% | 160,760 | -66.0% | 1.23% | -62.4% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $30,264,000 | -56.1% | 264,340 | -54.7% | 1.21% | -50.3% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $30,071,000 | -1.9% | 1,751,342 | +27.7% | 1.20% | +10.8% |
| HALO | Sell | HALOZYME THERAPEUTICS INC | $29,473,000 | -5.2% | 649,052 | -12.9% | 1.18% | +7.1% |
| VTR | Sell | VENTAS INC | $27,958,000 | -54.4% | 489,640 | -57.4% | 1.12% | -48.5% |
| THC | New | TENET HEALTHCARE CORP | $25,200,000 | – | 376,180 | +100.0% | 1.01% | – |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $23,784,000 | -83.4% | 117,960 | -82.3% | 0.95% | -81.2% |
| INCY | New | INCYTE CORPcall | $22,463,000 | – | 267,000 | +100.0% | 0.90% | – |
| DXCM | Sell | DEXCOM INC | $21,730,000 | -57.5% | 50,890 | -64.2% | 0.87% | -51.9% |
| LGV | New | LONGVIEW ACQUISITION CORP II | $20,932,000 | – | 2,135,900 | +100.0% | 0.84% | – |
| AFMD | Buy | AFFIMED N V | $20,595,000 | +64.0% | 2,422,964 | +52.6% | 0.82% | +85.4% |
| IDXX | Buy | IDEXX LABS INC | $18,883,000 | +109.6% | 29,900 | +62.4% | 0.76% | +136.7% |
| CYTK | Buy | CYTOKINETICS INC | $14,829,000 | +37.8% | 749,310 | +62.0% | 0.59% | +55.6% |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $14,138,000 | – | 386,190 | +100.0% | 0.56% | – |
| RACB | Buy | RESEARCH ALLIANCE CORP II | $13,433,000 | +31.1% | 1,324,800 | +32.5% | 0.54% | +47.9% |
| ARYD | Buy | ARYA SCIENCES ACQU CORP IVcl a | $13,281,000 | +9.4% | 1,238,881 | +6.9% | 0.53% | +23.5% |
| LIVN | New | LIVANOVA PLC | $10,514,000 | – | 125,000 | +100.0% | 0.42% | – |
| MSAC | New | MEDICUS SCIENCES ACQUISITION | $7,180,000 | – | 744,000 | +100.0% | 0.29% | – |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $6,727,000 | -18.3% | 522,712 | -29.0% | 0.27% | -7.6% |
| RAPT | New | RAPT THERAPEUTICS INC | $6,358,000 | – | 200,000 | +100.0% | 0.25% | – |
| GHRS | New | GH RESEARCH PLCordinary shares | $5,433,000 | – | 250,000 | +100.0% | 0.22% | – |
| IKNA | Buy | IKENA ONCOLOGY INC | $5,301,000 | -45.0% | 377,551 | +10.6% | 0.21% | -37.8% |
| OHPA | New | ORION ACQUISITION CORP | $5,290,000 | – | 547,598 | +100.0% | 0.21% | – |
| CMLT | New | CM LIFE SCIENCES III INC | $5,160,000 | – | 500,000 | +100.0% | 0.21% | – |
| NVAX | New | NOVAVAX INCput | $4,989,000 | – | 23,500 | +100.0% | 0.20% | – |
| ABGI | Sell | ABG ACQUISITION CORP I | $3,228,000 | -6.8% | 329,400 | -5.9% | 0.13% | +5.7% |
| GLPG | Buy | GALAPAGOS NVspon adr | $2,830,000 | +7.2% | 41,080 | +19.9% | 0.11% | +21.5% |
| OMEG | Sell | OMEGA ALPHA SPACcl a | $2,697,000 | -27.4% | 271,038 | -27.7% | 0.11% | -17.6% |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $2,687,000 | -5.4% | 262,150 | 0.0% | 0.11% | +7.0% | |
| CYT | New | CYTEIR THERAPEUTICS INC | $2,568,000 | – | 120,000 | +100.0% | 0.10% | – |
| EUCRU | Sell | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $2,389,000 | -28.9% | 234,180 | -29.9% | 0.10% | -20.2% |
| DAWN | New | DAY ONE BIOPHARMACEUTICALS I | $2,362,000 | – | 103,717 | +100.0% | 0.09% | – |
| GLUE | New | MONTE ROSA THERAPEUTICS INC | $2,270,000 | – | 100,000 | +100.0% | 0.09% | – |
| MRUS | Buy | MERUS N V | $2,032,000 | +60.8% | 96,438 | +59.4% | 0.08% | +80.0% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $1,824,000 | -12.3% | 268,295 | +32.4% | 0.07% | -1.4% |
| JYAC | JIYA ACQUISITION CORP | $1,398,000 | +1.0% | 140,680 | 0.0% | 0.06% | +14.3% | |
| ATAI | New | ATAI LIFE SCIENCES NV | $1,388,000 | – | 75,000 | +100.0% | 0.06% | – |
| ELEV | New | ELEVATION ONCOLOGY INC | $1,357,000 | – | 100,000 | +100.0% | 0.05% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,068,000 | – | 11,000 | +100.0% | 0.04% | – |
| LGVWS | New | LONGVIEW ACQUISITION CORP II*w exp 99/99/999 | $585,000 | – | 427,178 | +100.0% | 0.02% | – |
| MREO | MEREO BIOPHARMA GROUP PLCads | $473,000 | -6.0% | 149,170 | 0.0% | 0.02% | +5.6% | |
| CMLTW | New | CM LIFE SCIENCES III INC*w exp 04/30/202 | $258,000 | – | 99,998 | +100.0% | 0.01% | – |
| OHPAW | New | ORION ACQUISITION CORP*w exp 02/19/202 | $131,000 | – | 137,305 | +100.0% | 0.01% | – |
| MSACW | New | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $83,000 | – | 82,663 | +100.0% | 0.00% | – |
| BCTG | Exit | BCTG ACQUISITION CORP | $0 | – | -41,032 | -100.0% | -0.02% | – |
| ANIK | Exit | ANIKA THERAPEUTICS INC | $0 | – | -13,540 | -100.0% | -0.02% | – |
| HLXA | Exit | HELIX ACQUISITION CORP | $0 | – | -60,027 | -100.0% | -0.02% | – |
| OMER | Exit | OMEROS CORP | $0 | – | -50,000 | -100.0% | -0.03% | – |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -60,000 | -100.0% | -0.04% | – |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -265,580 | -100.0% | -0.05% | – |
| CMIIU | Exit | CM LIFE SCIENCES II INCunit 02/25/2028 | $0 | – | -173,563 | -100.0% | -0.08% | – |
| FNCH | Exit | FINCH THERAPEUTICS GROUP INC | $0 | – | -150,000 | -100.0% | -0.09% | – |
| FSII | Exit | FS DEVELOPMENT CORP II | $0 | – | -350,000 | -100.0% | -0.12% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -200,000 | -100.0% | -0.18% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWcall | $0 | – | -255,000 | -100.0% | -0.19% | – |
| CERN | Exit | CERNER CORP | $0 | – | -74,420 | -100.0% | -0.19% | – |
| OHPAU | Exit | ORION ACQUISITION CORPunit 02/19/2026 | $0 | – | -582,920 | -100.0% | -0.21% | – |
| MSACU | Exit | MEDICUS SCIENCES ACQUISITIONunit 99/99/9999 | $0 | – | -790,000 | -100.0% | -0.28% | – |
| INNV | Exit | INNOVAGE HLDG CORP | $0 | – | -325,000 | -100.0% | -0.30% | – |
| ICUI | Exit | ICU MED INC | $0 | – | -43,960 | -100.0% | -0.32% | – |
| CRIS | Exit | CURIS INC | $0 | – | -977,950 | -100.0% | -0.39% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -950,000 | -100.0% | -0.44% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -180,000 | -100.0% | -0.46% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -536,970 | -100.0% | -0.53% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -618,520 | -100.0% | -0.55% | – |
| HAE | Exit | HAEMONETICS CORP MASS | $0 | – | -148,480 | -100.0% | -0.58% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -227,450 | -100.0% | -0.61% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -494,640 | -100.0% | -0.62% | – |
| LGVU | Exit | LONGVIEW ACQUISITION CORP IIunit 99/99/9999 | $0 | – | -1,750,000 | -100.0% | -0.62% | – |
| SHC | Exit | SOTERA HEALTH CO | $0 | – | -805,220 | -100.0% | -0.71% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -900,490 | -100.0% | -0.82% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -207,610 | -100.0% | -0.84% | – |
| RPRX | Exit | ROYALTY PHARMA PLC | $0 | – | -590,790 | -100.0% | -0.91% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -90,000 | -100.0% | -1.02% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -135,000 | -100.0% | -1.06% | – |
| NUAN | Exit | NUANCE COMMUNICATIONS INC | $0 | – | -742,030 | -100.0% | -1.15% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -91,760 | -100.0% | -1.16% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -219,300 | -100.0% | -1.18% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -85,000 | -100.0% | -1.19% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -276,940 | -100.0% | -1.28% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -838,414 | -100.0% | -1.44% | – |
| COO | Exit | COOPER COS INC | $0 | – | -113,167 | -100.0% | -1.54% | – |
| IQV | Exit | IQVIA HLDGS INC | $0 | – | -401,690 | -100.0% | -2.74% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -729,420 | -100.0% | -2.79% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -1,532,960 | -100.0% | -2.80% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -1,144,287 | -100.0% | -3.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.